Drugs such as semaglutide, liraglutide, exenatide, and dulaglutide have been shown to significantly reduce body weight, BMI, and BMI z-score in children and adolescents, with semaglutide demonstrating the greatest efficacy among the class
GLP-1 receptors are located in the brain, and GLP-1 is created in the brain in preproglucagon neurons
Semaglutide is a medication known as a GLP-1 receptor agonist
Weight regain following GLP-1 discontinuation occurs gradually but consistently in most patients
When first starting out or moving up in dosage instead of having a high fibre intake, for the first few days opt for low residue foods such as cucumbers, carrots, spinach and white potatoes to reduce the risk of nausea
As obesity becomes more firmly recognized as a chronic metabolic disease, the gap between diabetes and weight loss treatment pathways may narrow